Is our current view of Guillain-Barre Syndrome recovery and treatment incomplete? [abstract]

Guillain-Barre Syndrome (GBS) is characterized by rapid onset of ascending paralysis, followed by slower recovery. Studies demonstrate that IVIg and plasmapheresis expedite recovery, but treatment protocols are based on studies that used 6 -12 month functional outcome measures terminated at ambulation of distances less than household distances. This study looks at outcomes >1 year to determine if patients' recovery expectations are met, if recovery continues beyond 6 months, and if more sensitive measures of long-term outcome exist